Locations:

Progress Toward a Fluid-Structure Interaction Model of Cerebral AVMs

Singular research aims to enhance prediction of rupture

arteriovenous malformation

A Cleveland Clinic research team is developing a quantitative model that can characterize the integrity of an arteriovenous malformation (AVM) based on fluid-structure interactions to more accurately evaluate rupture risk.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Determining whether a blood vessel can withstand the flow of blood is key to predicting whether an aneurysm or AVM is likely to rupture. At present, however, predicting such an event — and deciding whether to recommend a potentially risky intervention to prevent it — must be based mostly on evidence from retrospective studies and a neurosurgeon’s own experience.

“In cerebrovascular neurosurgery, each patient evaluation involves perilous decisions,” says the research team leader, Nina Moore, MD, a Cleveland Clinic neurosurgeon with a background in biomedical engineering. “There is a critical need for a better evaluation strategy based on a patient’s unique anatomy.”

A backdrop of risk and uncertainty

AVMs are particularly risky from an engineering perspective, as they consist of abnormally high-flow artery-to-vein connections, explains Dr. Moore. And hemorrhage often has dire clinical consequences: 20% of initial survivors die in the first three months, and about 45% of the remaining survivors are left with severe disability, with another 30% sustaining mild to moderate neurologic deficits.

Certain qualitative features can help classify an AVM as higher-risk, such as the presence of an intranidal aneurysm, a prior hemorrhage, venous outlet stenosis, deep location, sole deep venous drainage, small size and associated flow-related aneurysms.

But even after estimating risk based on these factors, management decisions can be difficult, compounding uncertainty about true risk. Medical management alone with blood pressure control, high-risk behavior reduction and routine surveillance may not be adequate to prevent an event. At the same time, intervention — whether with resection, radiation, embolization or a combination of these strategies — entails potential hazards of its own.

Advertisement

“The high stakes and uncertainty make having a risk-prediction model based on more quantitative factors all the more important,” says Dr. Moore.

Basing risk on fluid-structure interaction

The pressure of blood flow and the integrity of the blood vessel wall are the key factors in determining whether a hemorrhage will occur. Dr. Moore likens fluid-structure interaction modeling to trying to determine if a water balloon will burst: one needs to know not only the water pressure but also the strength of the balloon itself.

She says that while other investigators are focusing on determining AVM risk based on fluid dynamics, her team is the only group she knows of that is also incorporating blood vessel structural characteristics into a model.

Four broad research aims

Dr. Moore’s laboratory has four primary aims, she explains.

1) Understand the histologic and mechanical structures of cerebrovascular tissue. Using human cadaver heads, the lab’s investigators are focusing on histologic properties of cerebral arteries and veins by measuring elastin thickness relative to overall vessel thickness and diameter. Findings will be compared with data from the International Study of Unruptured Intracranial Aneurysms, which serves as an atlas for fluid-structure interaction modeling parameters for vessel thickness.

The team is also designing a mechanical testing rig to assess the viscoelasticity of cerebral arteries and veins. A pilot rig has been developed that uses a laser device to measure distension of vessels with pressures within the normal physiologic range. This will enable expansion of current modeling of cerebral vasculature to accurate structural data for fluid-structure interaction modeling.

Advertisement

2) Understand the fluid flow properties of cerebral AVMs. Fluid flow and pressure monitoring is being evaluated with a simple AVM simulated with 3D printing software (Figure). The system is in line with a cardiac pump to simulate blood flow through the normal range of blood pressures, with pressure and flow probes connected at different parts of the 3D-printed AVM model. A port of injection is included in the flow circuit to allow for angiographic injectors to be connected and thereby test the increase in flow through the circuit.

Fistereolithography rendering of a simple AVM 3D-printed flow model.

Figure. Stereolithography rendering of a simple AVM 3D-printed flow model.

3) Incorporate fluid flow and mechanical structure properties of vessels into a fluid-structure interaction model. Data from the first two aims will be combined to create a fluid-structure interaction model to be used initially for simple, and then increasingly complex, AVMs. “A model of this type will enable us to preoperatively predict rupture patterns within cerebral AVMs,” Dr. Moore explains. “It will also help neurosurgeons develop better strategies for AVM intervention by modeling the effects of tying off different vessels so that we can more safely determine which should be eliminated first.”

4) Determine patient AVM anatomy via imaging. The research team is mapping out AVM nidus anatomy by comparing results from different imaging modalities and examining en bloc resections. Intraoperative measurements, taken with a transonic probe, are used in 3D renderings for flow model evaluation.

Advertisement

“Our overarching goal is to have a validated model in about five years,” says Dr. Moore. “We expect it to offer a leap forward for evaluating and predicting AVM behavior.”

Advertisement

Related Articles

woman in lab holding two vials filled with liquids
October 19, 2026/Neurosciences/Brain Health

CSF and Plasma Analytes Reveal Early Clues to Alzheimer’s Development

Inflammatory protein eotaxin-1 may be a marker of future cognitive decline

headshots of Drs. Lilly and Barron

Early Mobilization in Neuro Intensive Care (Podcast)

Therapists and physicians collaborate to get medically stable patients moving

23-NEU-3627359-CQD-Hero-650×450

6 Things to Know About the New Home of Our Neurological Institute

Designed for digitization, distance health, discovery and more

illustration of a bright clinical room with clinicians inside

Inside Our Neurological Institute’s Next-Generation Advanced Therapeutics Space

Combining customized care, research capabilities and flexibility for the future

stylized illustration of human brain made up of cogs and wheels
October 9, 2026/Neurosciences/Brain Health

How Alzheimer’s Disease Studies Need to Evolve in the Targeted Therapy Era

Leading investigators outline a new roadmap for clinical trials and observational research

Older man tending to houseplants

TEMPO-2 Trial Shows Promise for Tavapadon in Newly Diagnosed Parkinson’s Disease

The selective D1/D5 dopamine agonist provides symptom relief and improves daily function.

illustration of human brain with swirls of activity inside it
September 23, 2026/Neurosciences/Brain Health

Cleveland ADRC Renewal Boosts Research Into Alzheimer’s Progression

5-year funding award supports cohort expansion and deep phenotyping of AD and related dementias

young man meditating on a sofa
September 21, 2026/Neurosciences/Epilepsy

Lifestyle Interventions Show Promise as Adjunctive Epilepsy Management

Highest response rates seen with stress-lowering techniques like yoga, meditation and mindfulness

Ad